TCL Archive Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL December 27, 2013
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive In Brief: FASEB Letter urges Support Of NIH, NSF; Kansas Recruits Experts From Washington State July 30, 1993
